INZY logo

Inozyme Pharma, Inc. (INZY)

Profile

Full Name

Inozyme Pharma, Inc.

Ticker

NASDAQ: INZY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 2020

Indexes

Not included

Website

http://www.inozyme.com

Employees

67

Key Details

Price

$4.00

Market cap

$258.25M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.62(-18.25% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.00
    INZY price is $4.00

    30-Day Relative Volume

    0.00
    INZY 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    -
    INZY price change on Jul 2, 2025 is unknown

    Price YTD change

    +44.4%
    INZY price is up +44.4% since January 1st

    Price 1-year change

    -30.92%
    INZY price is down -30.92% year-on-year

    Price 3-year change

    +11.42%
    INZY price is up +11.42% over the past 3 years

    Price Range

    Price All-time high

    $31.65
    INZY price is currently -87.36% below its historical high of $31.65

    Price 3-year low

    $0.72
    INZY price is currently +454.79% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $258.25M
    INZY market capitalization is $258.25 million

    Market cap 3-year change

    +79.4%
    INZY market capitalization is up +79.4% over the past 3 years

    Market cap All-time high

    $705.62M
    INZY market capitalization is currently -63.40% below its historical high of $705.62 million

    Market cap sector rank

    -
    INZY market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.01%
    INZY shares outstanding is up +4.01% year-on-year

    Shares Outstanding 3-Year Change

    +61.01%
    INZY shares outstanding is up +61.01% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.59
    INZY beta is 1.59

    200-day SMA

    $2.77
    INZY price is currently +44.29% above its 200-day simple moving average

    50-day SMA

    $2.98
    INZY price is currently +34.44% above its 50-day simple moving average

    RSI

    82.87
    INZY 14-day relative strength index is 82.87

    Volume

    0.00
    INZY 30-day relative volume is 0.00

    ATR

    $0.02
    INZY average true range is $0.02

    10-day Historical Volatility

    2.31%
    INZY 10-day historical volatility is 2.31%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    INZY annual revenue value is unknown

    Revenue Analysts estimate

    -
    INZY annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    INZY annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    INZY annual revenue is unknown

    EPS

    EPS

    -$1.62
    INZY annual earnings per share is -$1.62

    EPS Analysts estimate

    -$1.15
    INZY annual earnings per share is currently +41.48% higher than the consensus analysts' forecast

    EPS 1-year change

    -18.25%
    INZY annual earnings per share is down -18.25% year-on-year

    EPS Sector rank

    -
    INZY annual earnings per share is unknown

    Profit

    Gross profit

    -
    INZY annual gross profit value is unknown

    Gross margin

    -
    INZY annual gross profit margin value is unknown

    Operating profit

    -$104.03M
    INZY annual operating income is -$104.03 million

    Operating margin

    -
    INZY annual operating profit margin value is unknown

    Net income

    -$102.02M
    INZY annual net profit is -$102.02 million

    Net margin

    -
    INZY annual net profit margin value is unknown

    Expenses

    Total expenses

    $104.03M
    INZY annual total expenses is $104.03 million

    Operating expenses

    $104.03M
    INZY annual total operating expenses is $104.03 million

    Cost of goods sold

    -
    INZY annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $20.80M
    INZY annual SGA is $20.80 million

    Depreciation and amortization

    $742.00K
    INZY annual depreciation & amortization is $742.00 thousand

    Interest expense

    $5.56M
    INZY annual interest expense is $5.56 million

    Income tax

    -
    INZY annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$96.47M
    INZY annual earnings before interest & taxes is -$96.47 million

    EBITDA

    -$95.72M
    INZY annual EBITDA is -$95.72 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $123.18M
    INZY annual total assets is $123.18 million

    Non current assets

    $2.51M
    INZY annual long term assets is $2.51 million

    Current assets

    $120.68M
    INZY annual total current assets is $120.68 million

    Cash and cash equivalents

    $21.08M
    INZY annual cash & cash equivalents is $21.08 million

    Accounts receivable

    -
    INZY annual accounts receivable value is unknown

    Inventory

    -
    INZY annual inventory value is unknown

    Liabilities

    Total liabilities

    $65.36M
    INZY annual total liabilities is $65.36 million

    Long term liabilities

    $31.46M
    INZY annual total long term liabilities is $31.46 million

    Current liabilities

    $33.90M
    INZY annual total current liabilities is $33.90 million

    Accounts payable

    $2.53M
    INZY annual accounts payable is $2.53 million

    Debt

    Total debt

    $46.87M
    INZY annual total debt is $46.87 million

    Total debt 1-year change

    +0.6%
    INZY annual total debt is up +0.6% year-on-year

    Long term debt

    $31.46M
    INZY annual long term debt is $31.46 million

    Short term debt

    $15.41M
    INZY annual short term debt is $15.41 million

    Equity & Capital

    Shareholders equity

    $57.83M
    INZY annual stockholders equity is $57.83 million

    Book value

    $57.83M
    INZY annual book value is $57.83 million

    Retained earnings

    -$387.95M
    INZY annual retained earnings is -$387.95 million

    Working capital

    $86.78M
    INZY annual working capital is $86.78 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$91.91M
    INZY annual cash flow from operations is -$91.91 million

    Cash from operations 1-year change

    -30.04%
    INZY annual cash flow from operations is down -30.04% year-on-year

    Cash from investing

    $67.00M
    INZY annual cash flow from investing activities is $67.00 million

    Cash from investing 1-year change

    +224.89%
    INZY annual cash flow from investing activities is up +224.89% year-on-year

    Cash from financing

    $11.40M
    INZY annual cash flow from financing activities is $11.40 million

    Cash from financing 1-year change

    -90.95%
    INZY annual cash flow from financing activities is down -90.95% year-on-year

    CAPEX

    CAPEX

    -
    INZY annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    INZY annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$91.97M
    INZY annual free cash flow is -$91.97 million

    Free cash flow 1-year change

    -29.58%
    INZY annual free cash flow is down -29.58% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    INZY annual gross profit margin value is unknown

    Operating margin

    -
    INZY annual operating profit margin value is unknown

    Net margin

    -
    INZY annual net profit margin value is unknown

    ROA & ROE

    ROA

    -82.82%
    INZY annual return on assets is -82.82%

    ROE

    -176.43%
    INZY annual return on equity is -176.43%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    INZY price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    INZY price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.12
    INZY price to book ratio is 8.12

    PB ratio Sector rank

    -
    INZY price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    INZY price to sales ratio value is unknown

    PS ratio Sector rank

    -
    INZY price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $279.36M
    INZY enterprise value is $279.36 million

    Enterprise value Sector rank

    -
    INZY enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -2.78
    INZY EV/EBITDA is -2.78

    EV/EBITDA Sector rank

    -
    INZY EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.56
    INZY annual current ratio is 3.56

    Quick ratio

    -
    INZY annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.81
    INZY annual debt to equity ratio is 0.81

    Interest coverage ratio

    -17.36
    INZY annual interest coverage ratio is -17.36

    Risk & Stability

    Piotroski F-Score

    -
    INZY piotroski f-score value is unknown

    Altman Z-Score

    -
    INZY altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 16, 25 Wells Fargo
    Equal-Weight
    May 16, 25 Needham
    Hold
    May 16, 25 Jefferies
    Hold
    May 14, 25 Needham
    Buy
    Apr 10, 25 HC Wainwright & Co.
    Buy
    Apr 8, 25 Needham
    Buy
    Mar 12, 25 Raymond James
    Outperform
    Mar 11, 25 Piper Sandler
    Overweight
    Mar 11, 25 Needham
    Buy
    Mar 11, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with INZY included

    No data
    • What is the ticker symbol for Inozyme Pharma, Inc.?
    • Does Inozyme Pharma, Inc. pay dividends?
    • What sector is Inozyme Pharma, Inc. in?
    • What industry is Inozyme Pharma, Inc. in?
    • What country is Inozyme Pharma, Inc. based in?
    • When did Inozyme Pharma, Inc. go public?
    • Is Inozyme Pharma, Inc. in the S&P 500?
    • Is Inozyme Pharma, Inc. in the NASDAQ 100?
    • Is Inozyme Pharma, Inc. in the Dow Jones?
    • When was Inozyme Pharma, Inc.'s last earnings report?
    • When does Inozyme Pharma, Inc. report earnings?

    What is the ticker symbol for Inozyme Pharma, Inc.?

    The ticker symbol for Inozyme Pharma, Inc. is NASDAQ:INZY

    Does Inozyme Pharma, Inc. pay dividends?

    No, Inozyme Pharma, Inc. does not pay dividends

    What sector is Inozyme Pharma, Inc. in?

    Inozyme Pharma, Inc. is in the Healthcare sector

    What industry is Inozyme Pharma, Inc. in?

    Inozyme Pharma, Inc. is in the Biotechnology industry

    What country is Inozyme Pharma, Inc. based in?

    Inozyme Pharma, Inc. is headquartered in United States

    When did Inozyme Pharma, Inc. go public?

    Inozyme Pharma, Inc.'s initial public offering (IPO) was on July 24, 2020

    Is Inozyme Pharma, Inc. in the S&P 500?

    No, Inozyme Pharma, Inc. is not included in the S&P 500 index

    Is Inozyme Pharma, Inc. in the NASDAQ 100?

    No, Inozyme Pharma, Inc. is not included in the NASDAQ 100 index

    Is Inozyme Pharma, Inc. in the Dow Jones?

    No, Inozyme Pharma, Inc. is not included in the Dow Jones index

    When was Inozyme Pharma, Inc.'s last earnings report?

    Inozyme Pharma, Inc.'s most recent earnings report was on May 14, 2025

    When does Inozyme Pharma, Inc. report earnings?

    The next expected earnings date for Inozyme Pharma, Inc. is August 6, 2025
    On this page